Federal award (BPA CALL, fiscal year 2021)
Recipient: BRILLIENT CORPORATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2022-05-02 to 2023-01-27
Current total value of award: $64314
Description: EXPOSURE-BASED PARADIGM TO DEVELOP LONG-ACTING CONTRACEPTIVES